SHA:688253 Revenue

Innovita Biological Technology had revenue of 53.97M CNY in the quarter ending September 30, 2025, a decrease of -45.90%. This brings the company's revenue in the last twelve months to 430.96M, down -40.18% year-over-year. In the year 2024, Innovita Biological Technology had annual revenue of 621.39M with 29.99% growth.

Revenue (ttm)

430.96M

Revenue Growth

-40.18%

P/S Ratio

11.13

Revenue / Employee

787.87K

Employees

547

Market Cap

4.80B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	621.39M	143.37M	29.99%
Dec 31, 2023	478.02M	31.40M	7.03%
Dec 31, 2022	446.62M	119.71M	36.62%
Dec 31, 2021	326.91M	-710.19M	-68.48%
Dec 31, 2020	1.04B	899.09M	651.46%
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Hefei Lifeon Pharmaceutical	1.47B
Pulike Biological Engineering	1.10B
ChemPartner PharmaTech	1.07B
Beijing Bohui Innovation Biotechnology Group	834.38M
Zhejiang Shouxiangu Pharmaceutical	642.66M
Assure Tech (Hangzhou)	462.72M
Guanhao Biotech	392.83M
Beijing Scitop Bio-tech	351.47M

Revenue Rankings